ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281279 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281279; 2) Community: the network communities that were significantly associated with the response to NSC 281279; 3) Molecule: the relationships between components within communities and NSC 281279; 4) MDR: the compounds that were significantly associated with the NSC 281279.

NSC Compound Enrichment Correlation
NSC 105132 Deoxycamptothecin 0.029142074732756 0.28725513
NSC 175493 Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- 0.029142074732756 0.52419604
NSC 21683 Null 0.029142074732756 0.23263481
NSC 301457 Cycloalkannin 0.0321614375606958 0.48207534
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0321614375606958 0.47566881
NSC 625544 Null 0.0321614375606958 0.44015239
NSC 625731 Null 0.0321614375606958 0.37717381
NSC 626162 Discorhabdin C . TFA 0.0321614375606958 0.53322088
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0321614375606958 0.47106813
NSC 635449 Copper, chloro[2-[1-(2-pyridinyl)ethylidene][N,N-dipropyl-hydrazinecarbothioamidato-N,N,S]- 0.0321614375606958 0.35410097
Total:99  Current:65    [First] [Prev] [Next] [Last]